Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients.
about
Ventricular assist devices: pharmacological aspects of a mechanical therapyVeno-venous ECMO: a synopsis of nine key potential challenges, considerations, and controversiesBioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated.A modified technique for implantation of the HeartWare™ left ventricular assist device when using bivalirudin anticoagulation in patients with acute heparin-induced thrombocytopenia.Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices.Management of heparin-induced thrombocytopenia with fondaparinux in a patient with left ventricular assist device.Use of bivalirudin for anticoagulation during implantation of total artificial heart.Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation.Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients.Argatroban for an alternative anticoagulant in HIT during ECMO.Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenationUse of ventricular assist device as a bridge to cardiac transplantation: impact of age and other determinants on outcomes.Cerebrovascular complications of left ventricular assist devices.Paediatric mechanical circulatory support with Berlin Heart EXCOR: development and outcome of a 23-year experience.Anticoagulant monitoring in ventricular assist device patients: a feasibility study.Experience with over 1000 implanted ventricular assist devices.Role of paediatric assist device in bridge to transplant.Direct Thrombin Inhibitor for LVAD Thrombosis: A Closer Look.Mechanical circulatory support-results, developments and trends.
P2860
Q27002612-DC87AD3C-63B1-4B48-906E-21F0D38D5C90Q30365561-5C19A130-853F-4D15-BDBD-5961F5CBB9A5Q33385656-E398AD84-6266-4349-ACD4-68959BF6945CQ33407383-EFECD356-5626-4C29-9CC8-B7AF96DE2D95Q33410802-730DB07F-D039-483D-A1FC-18A67D5F91DCQ33416376-6AE77711-A283-434A-B8D2-0371D3647FF6Q33417601-CF6503FB-DFEE-4A8D-BD2F-5FCB538F3B66Q33440189-CEFA52F2-C0D3-460D-B93E-01349A6A1D26Q33442571-BDA4DD7C-3526-4E62-9DC3-89BCA10ACEDCQ33443354-F1A27E39-CB5B-40BE-95A7-5C570822C2FAQ36073211-F4DB0465-7846-436F-A8EC-9AC17583E49DQ37227870-28B5F2D5-A4EC-4840-8388-40E41AF43221Q38015693-18547B8E-7718-49EB-95AC-346F7D5CAFEDQ38746206-556D3962-B30A-489F-88C8-F5A42A86A599Q42546702-1EF87C6E-C6F2-4AE7-BC8F-0AAD08999585Q47751552-11379A2E-B1A7-44A9-9542-58BDE5795209Q50331554-7E1D993A-E376-408D-AB89-FD768AA0942AQ51130654-00DF5386-7DD8-47D5-B357-243008915203Q52897356-53230216-6D94-4CC5-8F07-594706299A75
P2860
Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@ast
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@en
type
label
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@ast
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@en
prefLabel
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@ast
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@en
P2093
P50
P1476
Impact of heparin-induced thro ...... e in 358 consecutive patients.
@en
P2093
Andreas Koster
Evgenij Potapov
Hermann Kuppe
Matthias Loebe
Michael Jurmann
Oliver Meyer
Sabine Huebler
Thorsten Drews
P356
10.1016/J.ATHORACSUR.2006.05.077
P407
P577
2007-01-01T00:00:00Z